Public Company News

BEST Inc. to Announce Second Quarter 2021 Financial Results on August 17, 2021

HANGZHOU, China, Aug. 3, 2021 /PRNewswire/ -- BEST Inc. (NYSE: BEST) ("BEST" or the "Company"), a leading integrated smart supply chain solutions and logistics services provider inChina, today announced that it will release its unaudited financial results for the second quarter endedJune 30 2021,...

2021-08-03 17:00 31633

Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction

HONG KONG and SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- Coller Capital ("Coller") and Ping An Overseas Holdings together with its subsidiaries ("Ping An"), the main offshore investment and asset management platform of Ping An Insurance (Group) Company ofChina, Ltd., have closed one of the world's la...

2021-08-03 16:05 5422

Coller Capital And Ping An Overseas Holdings Announce Closure Of One Of The World's Largest Private Credit Secondaries Transaction

HONG KONG and SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- Coller Capital ("Coller") and Ping An Overseas Holdings together with its subsidiaries ("Ping An"), the main offshore investment and asset management platform of Ping An Insurance (Group) Company ofChina, Ltd., have closed one of the world's la...

2021-08-03 16:05 4532

AiHuiShou International Co. Ltd. to Report Second Quarter 2021 Financial Results on August 17, 2021

SHANGHAI, Aug. 3, 2021 /PRNewswire/ -- AiHuiShou International Co. Ltd. ("ATRenew" or the "Company") (NYSE: RERE), a leading technology-driven pre-owned consumer electronics transactions and services platform inChina, today announced that it plans to release its unaudited financial results for t...

2021-08-03 16:00 7003

Tuya Smart Releases an All-In Bluetooth Development Capability

SANTA CLARA, Calif., Aug. 3, 2021 /PRNewswire/ -- Tuya Smart (NYSE: TUYA) a leading global IoT cloud platform, announced its latest developments of Bluetooth technology. In terms of Bluetooth protocol, Tuya Smart supports connection approaches such as point-to-point, Bluetooth mesh, and broadcas...

2021-08-03 15:24 7191

Nanoform and Boehringer Ingelheim execute master services agreement

HELSINKI, Aug. 3, 2021 /PRNewswire/ -- Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies may now be performed for Boehringer Ingelheim to assess the added value Nanoform's award-winning CESS® technology can deliver to its drug development proj...

2021-08-03 14:28 2853

GenScript Joins Forces with Allozymes by Providing Smart Libraries Construction for Precision Protein Engineering

SINGAPORE, Aug. 3, 2021 /PRNewswire/ -- GenScript Biotech Corporation (Stock Code: 1548.HK) today announced a collaboration with Allozymes, a synthetic biology company transforming ingredient manufacturing by unlocking protein engineering potential through groundbreaking technologies. In this par...

2021-08-03 12:05 9781

Jacobio Announces First Patient Dosed in Phase I/II Clinical Trial of KRAS G12C Inhibitor for Solid Tumor

BEIJING, Aug. 3, 2021 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) today announced the first patient was dosed in a Phase I/II clinical trial of KRAS G12C inhibitor JAB-21822 inChina. JAB-21822 is Jacobio's innovative in-house small molecule anti-cancer drug, which is designed to target t...

2021-08-03 09:00 4671

JD CENTRAL's Parent Company JD.com Ranks 59th on Fortune Global 500 List

BEIJING, Aug. 3, 2021 /PRNewswire/ -- JD.com, China's largest retailer and the parent company of JD CENTRAL, ranked 59th on the Fortune Global 500 list released onAugust 2. Up by 43 places comparing with last year, JD.com has made the list for the 6th consecutive year, as the largest "retail and ...

2021-08-03 08:53 32816

CStone announces positive registrational study of the first-in-class drug ivosidenib in Chinese patients with relapsed or refractory acute myeloid leukemia, and NDA has been accepted by the China NMPA and considered for Priority Review

* Ivosidenib (TIBSOVO®, the brand name in the U.S.) is the first isocitrate dehydrogenase 1 (IDH1) inhibitor inChina that has demonstrated its efficacy and manageable safety in patients with relapsed or refractory acute myeloid leukemia (R/R AML) * The National Medical Products Administration...

2021-08-03 08:05 4719

Iridium Granted Trio of Regulatory Approvals in Japan

A combination of new aviation, land and maritime service approvals brings state-of-the-art Iridium® SATCOM to Japanese flagged aircraft, ships and vehicles MCLEAN, Va., Aug. 3, 2021 /PRNewswire/ -- Iridium Communications Inc. (NASDAQ: IRDM) today announced thatJapan's Ministry of Internal Affair...

2021-08-03 06:01 8012

Hollysys Board of Directors Evaluating Offers From Consortiums

BEIJING, Aug. 2, 2021 /PRNewswire/ -- HollySys Automation Technologies Ltd. (NASDAQ: HOLI) ("HollySys" or the "Company"), a leading provider of automation and control technologies and applications inChina, today announced that the Company's Board of Directors (the "Board") is in the process of ev...

2021-08-03 04:55 30850

iPower Inc Doubles Warehouse Capacity with New Facility in California

DUARTE, Calif., August 2, 2021 /PRNewswire/ -- iPower Inc. (Nasdaq:IPW), one of the leading online hydroponic equipment suppliers and retailers in theUnited States, today announced that it has entered into an agreement to lease a new warehouse and logistics facility inRancho Cucamonga, CA.   "W...

2021-08-03 00:47 30124

Cardinal Health completes sale of Cordis business to Hellman & Friedman

DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...

2021-08-02 23:00 4435

Cardinal Health completes sale of Cordis business to Hellman & Friedman

DUBLIN, Ohio, Aug. 2, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) and Hellman & Friedman (H&F) announced today the completion of the previously announced sale of Cardinal Health's Cordis business to H&F. The sale price of approximately$1 billion includes the buyer's assumption of certain lia...

2021-08-02 23:00 4014

Products Empowered by Tuya Smart Design Win iF DESIGN AWARD 2021 and Red Dot Design Award 2021

SANTA CLARA, Calif., Aug. 2, 2021 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a global leading IoT cloud platform, celebrates the products empowered byTuya Smart's industrial design team that won this year's iF DESIGN AWARD and Red Dot Design Award. The WL2 Smart Camera

2021-08-02 21:17 7566

Tuya Smart Launches Tuya Beacon to Empower Intelligent Transformation Across all Scenarios

SANTA CLARA, Calif., Aug. 2, 2021 /PRNewswire/ -- Tuya Smart (NYSE: TUYA), a global leading IoT cloud platform, has launched Tuya Beacon, a cost-effective, easy to deploy, remote controlled, and developer-friendly Bluetooth protocol to empower the intelligent upgrade and transformation of smar...

2021-08-02 20:54 7245

Greenland Technologies to Report Second Quarter 2021 Unaudited Financial Results on Tuesday, August 10, 2021

EAST WINDSOR, N.J., Aug. 2, 2021 /PRNewswire/ -- Greenland Technologies Holding Corporation (NASDAQ: GTEC) ("Greenland"), a technology developer and manufacturer of electric industrial vehicles and drivetrain systems for material handling machineries and vehicles, today announced that it will re...

2021-08-02 20:30 28990

Ping An Ranks 16th in the Fortune Global 500 List, 2nd Among Global Financial Enterprises

HONG KONG and SHANGHAI, Aug. 2, 2021 /PRNewswire/ -- With sustained performance and growth, Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An " or the "Group", HKEX: 2318; SSE: 601318) ranked 16th on the 2021 Fortune Global 500 list, climbing five places since last year. With rev...

2021-08-02 20:22 32851

WuXi Biologics Biosafety Testing Facility Received Second EMA GMP Certificate

SUZHOU, China, Aug. 2, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that only 13 months after receiving its first GMP certificate, it has once again received a European Medicines Agency (EMA) GMP c...

2021-08-02 20:13 4462